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Mammalian Dicer interacts with 
double-stranded RNA binding protein 
TRBP or PACT to mediate RNA 
interference and microRNA processing. 
TRBP and PACT are structurally related, 
but exert opposite regulatory activities on 
protein kinase PKR. It is not understood 
whether TRBP and PACT are 
simultaneously required for Dicer. Here 
we show that TRBP directly interacts 
with PACT in vitro and in mammalian 
cells. TRBP and PACT form a triple 
complex with Dicer and facilitate the 
production of small interfering RNA 
(siRNA) by Dicer. Knockdown of both 
TRBP and PACT in cultured cells leads to 
significant inhibition of gene silencing 
mediated by short hairpin RNA, but not 
by siRNA, suggesting that TRBP and 
PACT function primarily at the step of 
siRNA production. Taken together, these 
findings indicate that human TRBP and 
PACT directly interact with each other 
and associate with Dicer to stimulate the 
cleavage of double-stranded or short 
hairpin RNA to siRNA. Our work 
significantly alters the current model for 
the assembly and function of the Dicer-
containing complex that generates siRNA 
and microRNA in human. 
 
RNA interference (RNAi) is an 
evolutionarily conserved mechanism for 
gene silencing mediated through small 
RNAs of approximately 22 nucleotides in 
length (1). At least two classes of small 
RNAs have been described in mammals: 
microRNAs (miRNA) produced from 
hairpin precursors and small interfering 
RNAs (siRNAs) derived from long double-
stranded RNAs (dsRNAs) (2). Both 
miRNAs and siRNAs are generated by 
RNase III-type nuclease Dicer and they are 
assembled into effector complex termed 
RNA-induced silencing complex (RISC) (3, 
4). While two Dicer enzymes Dcr1 and Dcr2 
have been found in fruit flies and are 
responsible for the generation of miRNAs 
and siRNAs, respectively, there exists only 
one single Dicer in humans, which produces 
both miRNAs and siRNAs (3). Dcr2 is 
known to associate with a dsRNA binding 
protein (dsRBP) termed R2D2, which binds 
to siRNA and facilitates its passage from 
Dcr2 to RISC (5, 6).       
A new family of dsRBPs which includes 
Loquacious in Drosophila as well as TRBP 
and PACT in humans has recently been 
shown to interact with Dicer and be required 
for its function in RNAi (7-12). Unlike its 
counterparts in Drosophila that have only 
one dsRBP partner, human Dicer appears to 
associate with two closely related dsRBPs, 
TRBP and PACT (10-12). TRBP was 
originally identified and characterized by its 
high affinity for TAR, a hairpin RNA 
encoded by human immunodeficiency virus 
type 1 (13). PACT was initially cloned as a 
cellular protein activator of protein kinase 
PKR (14, 15). Although both PACT and 
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TRBP bind to PKR and have three similar 
dsRNA binding domains (dsRBDs), TRBP 
exerts an inhibitory effect on PKR (16-20). 
While both TRBP and PACT interact 
with and support the function of human 
Dicer in RNAi (10-12), it is not understood 
whether their binding with Dicer is 
simultaneous or mutually exclusive. TRBP 
and PACT are closely related and both are 
capable of homodimerization (21, 22). In 
addition, they share two binding partners, 
PKR and Dicer (10-12, 16-20). This raises 
the possibility that TRBP and PACT might 
function as a protein complex in cells. In this 
study, we explored the direct interaction 
between TRBP and PACT as well as its 
impact on Dicer and RNA silencing.  
 
EXPERIMENTAL PROCEDURES 
 
Plasmids and siRNA – Human cDNAs 
for TRBP and PACT were derived from 
clones IRAUp969F1229 and 
DKFZp564I0123 obtained from RZPD 
(Berlin, Germany). Expression plasmids for 
TRBP and PACT were based on 
pcDNA3.1/V5-His (Invitrogen), 
pCMVTag3B (Stratagene), pGEX-4T1 
(Amersham), pMAL-c2X (New England 
Biolabs) and pET-28a (Novagen). Coding 
sequences of CFP and YFP were PCR-
amplified from plasmids pECFP-C1 and  
pEYFP-C1 (Clontech). Plasmid pshRL1776 
expressing shRL has been described 
elsewhere (23). Expression vectors for 
shTRBP, shPACT and shGFP were 
constructed using pSHAG-1 (24) and 
pshRL1776 as template. siRL and siDicer 
were chemically synthesized as previously 
described (25, 26). 
Protein Purification and Protein 
Analysis – GST-TRBP, MBP-TRBP, His-
PACT and GST-PACT as well as the 
truncated forms of His-TRBP and His-
PACT were expressed in E. coli BL21 (DE3) 
strain. GST fusion proteins were purified by 
glutathione-Sepharose column (Amersham) 
and eluted with 50 mM reduced glutathione. 
MBP-TRBP was purified through amylose 
resin (New England Biolabs) and eluted with 
10 mM maltose solution. Polyhistidine-
tagged proteins were purified through Ni-
chelating column (Qiagen) and eluted with 
200 mM imidazole. All fusion proteins were 
dialyzed overnight at 4oC. To remove 
contaminating RNA bound to TRBP/PACT, 
protein purification was performed in the 
presence of 200 µg of RNase A (Sigma). All 
proteins were purified to >90% homogeneity 
as verified by SDS-PAGE analysis. All 
preparations of purified proteins were free of 
contaminating RNA as measured by UV 
absorbance (OD260). GST pull down, co-
immunoprecipitation and Western blot 
analysis were carried out as described (27, 
28).  
Mouse monoclonal anti-V5 antibody was 
purchased from Invitrogen. Rabbit 
polyclonal anti-Myc serum was from Sigma. 
Mouse anti-Dicer and goat anti-T7 
antibodies were from Abcam. A rabbit anti-
TRBP serum was raised against purified 
recombinant GST-TRBP-A. Specificity of 
anti-TRBP antibodies was verified with 
lysate of TRBP-overexpressing HEK293T 
cells.  
Fluorescence Resonance Energy 
Transfer (FRET) Imaging – Multi-color 
fluorescence microscopy was performed as 
previously described (29, 30). HeLa cells 
were transfected with pcDNA-CFP-TRBP, 
pcDNA-YFP-PACT, or both. Cells were 
fixed with methanol/acetone (1:1, v/v) at 24 
hours post transfection. Fixed cells were 
excited either at 820 nm (for CFP excitation) 
or 488 nm (for YFP excitation) and signals 
were recorded at either 435-485 nm (signal 
for CFP) or 535-590 nm (signal for YFP) on 
a Zeiss LSM510 META laser scanning 
microscope. FRET signal was captured at 
535-590 nm during excitation at 820 nm. 
FRET signal between CFP and YFP was 
corrected using Zeiss LSM software.  
Protein Fractionation Analysis – Two 
C57 mouse testes were dissected and  
homogenized in 1 ml of MTPBS buffer with 
protease inhibitor (Roche) for 1 min on ice. 
Homogenized testes were centrifuged at 
14,000 × g for 30 min at 4oC. Protein lysates 
were treated with RNase A at 50 µg/ml for 
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15 min at 4oC and then passed through 0.22 
µm filter. Filtered lysates were loaded into 
Superdex 200 gel filtration column 
(Amersham) and were fractionated at 0.3 ml 
per min in MTPBS buffer. Fractions (1 ml 
each) were lyophilized overnight and 
redissolved in 100 µl of MTPBS buffer. 
Samples were analyzed by Western blotting 
with rabbit anti-TRBP, rabbit anti-PACT 
(Abcam) and mouse anti-Dicer (Abcam) 
antibodies. 
In vitro Dicer Cleavage Assay – dsRNA 
was transcribed in vitro using T7 RNA 
polymerase (Ambion) and purified with 
RNeasy reagents (Qiagen). Excess amount 
of dsRNA was incubated with recombinant 
human Dicer (Stratagene or Ambion) for 16 
hrs at 37oC. Cleavage products were purified 
by passing through G-25 (Amersham) and 
then YM-100 (Millipore) columns to remove 
salts and undigested dsRNA. Purified 
products were analyzed through urea 
polyacrylamide gel electrophoresis and 
stained with ethidium bromide. The purity of 
recombinant human DICER was verified by 
SDS-PAGE and a single discrete band of  
>200 kDa was seen. 
Northern Blot Analysis – RNA was 
isolated from cultured cells with mirVana 
miRNA isolation kit (Ambion). RNA on 
denaturing polyacrylamide gel was 
transferred onto ZetaProbe membrane 
(BioRad) using a semi-dry Transblot 
apparatus (Hoefer). RNA on the membrane 
was crosslinked and the n hybridized in 
ULTRAhyb-Oligo solution (Ambion) with 
32P-labeled RNA oligos that can hybridize to 
siRL. 
Luciferase Assay – Renilla luciferase 
activity was determined as described (23, 31) 
using the Dual-Luciferase® reagents 
(Promega). Transfection efficiencies were 
normalized to a control plasmid expressing 
firefly luciferase. 
 
RESULTS 
 
TRBP and PACT Interact Directly with 
Each Other – Because TRBP and PACT are 
related both structurally and functionally, we 
asked whether they bind to each other 
directly. We first performed GST pull down 
experiments with recombinant proteins 
purified from E. coli. We found that a 
polyhistidine-tagged PACT (His-PACT) 
bound with high affinity to GST-TRBP, but 
not to GST (Fig. 1A, lane 2 compared to 
lane 1, and lane 5 compared to lane 4). In 
agreement with the previous finding on 
homodimerization of PACT (22), we also 
observed the retention of His-PACT in the 
GST-PACT resin (Fig. 1A, lanes 3 and 6). 
To confirm the direct binding between 
TRBP and PACT, we employed another 
TRBP fusion protein MBP-TRBP. We noted 
that MBP-TRBP specifically bound to GST-
PACT resin, but not to GST alone (Fig. 1B, 
lane 4 compared to lane 2). In keeping with 
the concept of TRBP homodimerization (21), 
homophilic interaction between GST-TRBP 
and MBP-TRBP was also seen in this 
experiment (Fig. 1B, lane 6 compared to 
lane 2). Thus, our results from in vitro 
affinity binding assay consistently support 
that TRBP and PACT can not only form 
homodimers, but also interact directly with 
each other.  
TRBP and PACT contain three dsRBDs 
(Fig. 1C) that have differential activities in 
regulating PKR (17, 18) and in the formation 
of homodimers (21, 22). To determine the 
roles of the three dsRBDs in mediating 
TRBP-PACT interaction, we constructed 
two sets of truncated mutants and 
interrogated them for binding activities with 
TRBP or PACT using GST pull down assay. 
We found that PACT-A containing the first 
dsRBD was capable of binding to GST-
TRBP (Fig. 1C, lane 1), while the interaction 
with GST-PACT was mediated by TRBP-A 
and TRBP-B corresponding to the first and 
second dsRBDs, respectively (Fig. 1C, lanes 
4 and 5).    
Next we carried out co-
immunoprecipitation experiment to further 
investigate the interaction of TRBP with 
PACT in human cells. Immunoprecipitation 
and Western blotting were performed 
reciprocally with antibodies recognizing 
Myc-tagged TRBP (Myc-TRBP) and V5-
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tagged PACT (V5-PACT). Since both Myc-
TRBP and V5-PACT were found in the 
precipitates (Fig. 1D, lanes 4 and 8 
compared to lanes 3 and 7, respectively), the 
two entities plausibly formed a protein 
complex inside human cells in culture. To 
rule out the possibility that TRBP and PACT 
associate as a result of lysate preparation, 
Myc-TRBP and V5-PACT were also 
expressed in separate cells. Precipitation was 
then performed immediately after mixing the 
lysates of different cells. Because similar 
results were also obtained in this setting 
(data not shown), the interaction of TRBP 
and PACT was unlikely an artifact generated 
during the preparation of cell lysates. 
In a third approach, we used FRET 
imaging to analyze the interaction between 
TRBP and PACT. FRET imaging can detect 
the interaction between two proteins 
differentially fused with fluorescent tags. 
The FRET signal is emitted only when the 
two proteins are within a distance of less 
than 10 nm (32). In our experiment, both 
CFP-TRBP and YFP-PACT were found to 
localize in the cytoplasm (Fig. 2, panels 1 
and 5). No FRET signal was measurable 
when CFP-TRBP alone or YFP-PACT alone 
was expressed (Fig. 2, panels 3 and 6). In 
contrast, when cells co-expressing CFP-
TRBP and YFP-PACT were recorded 
simultaneously in the CFP, YFP and FRET 
channels, a significant FRET signal was 
observed (Fig. 2, panel 9). These results lent 
further support to the notion that TRBP and 
PACT interact directly with each other 
within human cells. 
Formation of TRBP-PACT-Dicer 
Complex in vitro and in Cultured Cells – 
The direct interaction between TRBP and 
PACT (Fig. 1 and Fig. 2) as well as the 
association of TRBP/PACT with Dicer (7-12) 
prompted us to ask whether TRBP, PACT 
and Dicer might function as a protein 
complex. In this regard, while the roles of 
TRBP and PACT in RNAi have been well 
described (10-12), two important questions 
remain unanswered. First, since the 
association of PACT with Dicer has been 
demonstrated by co-fractionation and co-
immunoprecipitation only (12), it is not 
known whether PACT directly interacts with 
Dicer or through TRBP. Second, it is not 
understood whether TRBP and PACT bind 
to Dicer simultaneously or exclusively. To 
address these questions, we performed in 
vitro protein affinity binding assays using 
bacterially produced TRBP, PACT and 
Dicer (Fig. 3A). Because recombinant Dicer 
was retained in the GST-PACT-bound resin 
as efficiently as in the resin containing GST-
TRBP (Fig. 3A, lane 1 compared to lane 4), 
the physical interaction between PACT and 
Dicer is direct and unlikely mediated 
through another protein. We then queried for 
the formation of triple complex by loading 
MBP-TRBP and Dicer sequentially to the 
GST-PACT resin. In this experiment, GST-
PACT was first saturated with an excess of 
MBP-TRBP and the unbound MBP-TRBP 
was then removed by extensive washing (Fig. 
3A, lane 2). Next, Dicer was added and 
found to be retained in the resin (Fig. 3A, 
lane 3). Likewise, when we saturated GST-
TRBP resin with excess His-PACT, washed 
away all free His-PACT and incubated the 
GST-TRBP-His-PACT-bound resin with 
Dicer, Dicer was also retained in the resin 
(Fig. 3A, lane 6 compared to lane 5). 
Reciprocally, MBP-TRBP or His-PACT was 
found in the resin if the GST-PACT or GST-
TRBP resin was first saturated with Dicer 
(data not shown). Collectively, our results 
are consistent with the formation of a stable 
triple complex of TRBP, PACT and Dicer.      
To verify that a protein complex 
containing TRBP, PACT and Dicer is also 
formed in cultured human cells, we 
performed reciprocal immunoprecipitation 
and Western blotting (Fig. 3B). While both 
Dicer and V5-PACT were found in the anti-
Myc precipitate that contained Myc-TRBP 
(Fig. 3B, lane 4 compared to lanes 1-3), both 
Dicer and Myc-TRBP were also detected in 
the precipitate containing V5-PACT (Fig. 
3B, lane 8 compared to lanes 5-7). Thus, 
TRBP and PACT likely bound with Dicer as 
a functional complex.  
We next compared the binding activities 
of truncated TRBP and PACT mutants (Fig. 
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3C). While the first two dsRBDs of TRBP 
(TRBP-A and TRBP-B) were responsible 
for interaction with TRBP and PACT, the 
third dsRBD (TRBP-C) was accounted for 
binding with Dicer. This is generally 
consistent with previous findings (8, 11). On 
the other hand, the first dsRBD of PACT 
(PACT-A) was necessary for binding to 
TRBP and PACT, whereas the second and 
third dsRBDs (PACT-B and PACT-C) were 
required for interaction with Dicer. Thus, 
TRBP and PACT used different domains to 
mediate their interaction with partner 
proteins. Interestingly, all truncated forms of 
TRBP and PACT were found to associate 
with Dicer in cultured cells, suggesting that 
some mutants incapable of binding with 
Dicer directly in vitro might interact with it 
indirectly through its TRBP or PACT 
partner. Moreover, when we pre-saturated 
recombinant Dicer with excess TRBP-C or 
PACT-C, other forms of TRBP or PACT 
was no longer able to bind with Dicer (data 
not shown), suggesting that TRBP and 
PACT likely compete for the same binding 
site(s) in Dicer.  
Formation of TRBP-PACT-Dicer 
Complex in Mouse Testicular Tissue – 
Consistent with a previous report (33), we 
found that TRBP and PACT were 
abundantly expressed in male germ cells 
(data not shown). Thus, we investigated the 
in vivo formation of TRBP-PACT-Dicer 
complex in mouse testicular tissue. As a first 
step, the specificity of polyclonal antibodies 
against endogenous TRBP, PACT and Dicer, 
which we prepared or purchased, was 
verified with human and mouse tissues as 
well as transfected cells. All three antibodies 
reacted with target proteins in human and 
mouse tissues and cells in a highly specific 
manner (data not shown). We then 
fractionated extracts of mouse testes through 
Superdex 200 gel filtration column and 
analyzed the fractions by Western blotting 
with anti-TRBP, anti-PACT and anti-Dicer 
antibodies (Fig. 4A). TRBP, PACT and 
Dicer were detected in fractions 40-43, 
consistent with the presence of a TRBP-
PACT-Dicer complex displaying a 
molecular mass of more than 440 kDa. The 
detection of multiple TRBP or PACT 
species in mammalian cells was consistent 
with previous reports (10, 11, 34).       
In keeping with the co-fractionation 
results, we also detected PACT and Dicer in 
the protein complex precipitated with anti-
TRBP (Fig. 4B, lanes 3 and 7).  Thus, our 
results suggested that endogenous TRBP, 
PACT and Dicer proteins associate to form a 
triple complex in mouse testicular tissue. 
Roles of TRBP and PACT in Dicer-
dependent Production of siRNA – The 
formation of a stable TRBP-PACT-Dicer 
complex led us to explore the influence of 
TRBP and PACT on Dicer function. In 
previous studies, comparison of the siRNA/ 
miRNA-producing activities of TRBP-Dicer 
or PACT-Dicer with Dicer alone suggest 
that neither TRBP nor PACT is required for 
the RNA cleavage reaction catalyzed by 
Dicer (10, 12). However, a Drosophila 
homolog of TRBP and PACT named 
Loquacious can stimulate the specific pre-
miRNA processing activity of Dicer-1 (8, 
35). Moreover, a dsRBP partner of 
Caenorhabditis elegans Dicer termed RDE-
4 also functions in concert with Dicer at the 
step of siRNA production (36). To clarify 
whether human TRBP, PACT or TRBP-
PACT complex could facilitate RNA 
processing by Dicer, we monitored the 
cleavage of dsRL566, a 566-bp long dsRNA 
corresponding to a fragment of Renilla 
luciferase mRNA. In reactions containing 
the same amount of recombinant Dicer and 
escalating amounts of GST-TRBP, His-
PACT or GST-TRBP plus His-PACT, a 
significant increase in the production of 
siRNA could be appreciated (Fig. 5). 
Notably, the increase in siRNA yield 
attributed to GST-TRBP plus His-PACT is 
comparable to the elevation ascribed to the 
same amount of GST-TRBP or His-PACT 
(Fig. 5, lanes 10-12 compared to lanes 4-6 
and 7-9). These results indicate the 
facilitation of Dicer-mediated production of 
siRNA by TRBP and PACT. In addition, a 
protein complex consisted of TRBP and 
PACT is at least equally active in facilitating 
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the production of siRNA by Dicer when 
compared to TRBP or PACT alone.          
In order to assess the roles of 
endogenous TRBP and PACT in RNA 
silencing in human cells, we knocked down 
the expression of TRBP or PACT effectively 
and specifically using short hairpin RNAs 
(shRNAs) in HEK293T cells (Fig. 6A and 
6B). We them performed Northern blot 
analysis to confirm that the production of 
siRNAs corresponding to the Renilla 
luciferase mRNA (siRL) was significantly 
diminished in TRBP- or PACT-depleted 
cells (Fig. 6C, lanes 3 and 4 compared to 
lane 2). Notably, the combined effect of 
shTRBP and shPACT was even more 
pronounced than that of shTRBP or shPACT 
alone (Fig. 6C, lane 5 compared to lanes 3 
and 4). Consistent with these results and 
with previous reports (10-12), depletion of 
TRBP or PACT by shRNAs also led to 
substantial inhibition of the gene-silencing 
activity of an shRNA targeting Renilla 
luciferase mRNA (shRL), which has been 
shown (23) to be highly effective and 
specific in blocking the expression of 
Renilla luciferase (Fig. 6D, columns 3-5 
compared to columns 1 and 2, and columns 
8-10 compared to columns 6 and 7). The 
observed effect was unlikely due to non-
specific saturation of the RNAi machinery 
by shRNA, since shGFP at the highest dose 
had no influence on shRL activity (Fig. 6D, 
column 16). The effectiveness of this shGFP 
in silencing GFP expression has been shown 
previously (23) and its abundant expression 
in HEK293T cells was confirmed by 
Western blotting (data not shown). Again, 
the combined effect of shTRBP and shPACT 
was greater than that of shTRBP or shPACT 
alone (Fig. 6D, columns 13-15 compared to 
columns 3-5 and 8-10). This was most 
evident at the lowest dose of shRNAs. In 
fact, the inhibitory activity of shTRBP + 
shPACT at the lowest dose was significantly 
higher than that of shTRBP alone or 
shPACT alone at the same dose (Fig. 6D, 
columns highlighted by # and *; P < 0.005 
by t-test). Thus, simultaneous knockdown of 
TRBP and PACT in cultured human cells 
had a significant impact on RNAi. In other 
words, TRBP and PACT likely cooperate 
with each other in facilitating the execution 
of RNA silencing. 
To address the concern of other non-
specific off-target effects, we performed 
additional control experiments by adding 
back TRBP or PACT. Because enforced re-
expression of TRBP was able to reverse the 
effect induced by shTRBP at the highest 
dose (Fig. 6D, column 17 compared to 
column 5), the inhibition of shRL-induced 
silencing by shTRBP was specific. Likewise, 
reversal of shPACT-induced inhibition by 
PACT (Fig. 6D, column 18 compared to 
column 10) verified the specificity of effect.    
In contrast to the above results obtained 
with shRL, depletion of endogenous TRBP 
and/or PACT in HEK293T by shTRBP/ 
shPACT had no influence on the silencing of 
Renilla luciferase expression induced by 
siRL, a synthetic siRNA targeting the same 
sequence on Renilla luciferase mRNA as 
shRL (Fig. 6E). As a positive control, 
depletion of Dicer by siRNA was effective 
in rescuing the siRL activity significantly 
(Fig. 6E, column 16), as demonstrated 
previously by others (26). Our results are 
surprising since TRBP and PACT have 
previously been shown to be required for 
siRNA-mediated silencing (10, 12). 
Nevertheless, taking into account the effects 
of shTRBP/shPACT on shRL (Fig. 6D) and 
siRL (Fig. 6E), we argued that TRBP and 
PACT function primarily at the step of 
siRNA production.    
 
DISCUSSION 
 
In this study, we established the direct 
interaction between human dsRBPs TRBP 
and PACT by using in vitro affinity binding 
assay (Fig. 1). This interaction was further 
verified by co-immunoprecipitation and 
FRET imaging (Fig. 1 and Fig 2). In 
addition, we demonstrated the direct 
interaction of PACT with Dicer and the 
formation of a TRBP-PACT-Dicer complex 
in vitro, in cultured human cells and in 
mouse testicular tissue (Fig. 3 and Fig. 4). 
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Finally, we provided the first evidence that 
human Dicer associated with TRBP and 
PACT is more active than Dicer alone in 
processing long dsRNA into siRNAs (Fig. 5). 
Accordingly, depletion of endogenous 
TRBP and PACT resulted in an inhibition of 
shRNA-induced gene silencing primarily at 
the step of siRNA production (Fig. 6). Our 
findings suggest a new model for the 
assembly and function of human Dicer 
complex in which TRBP and PACT directly 
interact with each other and bind 
simultaneously to Dicer to facilitate the 
production of siRNA (Fig. 7).    
While more than one Dicer have been 
found in Drosophila and plants (1, 37, 38), 
there is one single Dicer in humans and it is 
distinct from other members in the family of 
Dicer-like proteins by associating with two 
dsRBPs, TRBP and PACT (10-12). Our 
demonstration of the direct interaction 
between TRBP and PACT suggests another 
level of complexity in the regulation of 
RNAi in human cells. This is the first 
example of an interaction between two 
Dicer-associated dsRBPs. TRBP and PACT 
are two members in the family of dsRBPs 
that have diverse cellular functions (39). 
Several other dsRBPs have also been known 
to interact with Dicer-like proteins or with 
other RNase III endonucleases such as 
Drosha (5-8, 35, 40). Thus, it will be of 
interest to determine whether any of these 
dsRBPs might be binding partners. We 
demonstrated that TRBP and PACT use 
different domains to interact with each other 
and with Dicer (Fig. 3C). Noteworthily, all 
truncated mutants of TRBP and PACT can 
directly or indirectly bind with Dicer within 
cultured cells. Since there exist multiple 
naturally occurring isoforms of TRBP and 
PACT that contain only the first one or two 
dsRBDs (8, 11), further characterization of 
these isoforms for influence on Dicer 
function is warranted. In addition, because 
TRBP and PACT use the same dsRBD(s) to 
mediate homodimerization and interaction 
with each other (Fig. 3C), it is possible that 
TRBP and PACT function as a stable 
heterodimer in vitro and in vivo. Dicer has 
been shown to form an intramolecular 
pseudodimer (41). Thus, additional 
biochemical and biophysical analyses are 
required to elucidate the protein 
stoichiometry and structure of TRBP-PACT-
Dicer complex. In this regard, it will also be 
of importance to compare the specific 
activities of TRBP and PACT homo- and 
heterodimers in terms of dsRNA-binding, 
interaction with Dicer and modulation of 
PKR.         
Both TRBP and PACT have been shown 
to interact with PKR and to regulate its 
activity (14-20). Moreover, their interaction 
with PKR has functional implications in 
inflammation, stress response, viral infection 
and oncogenesis (20, 34, 42-44). While 
TRBP and PACT directly interact with each 
other (Fig. 1), it remains to be understood 
whether they associate in vivo with PKR as a 
TRBP-PACT heterodimer and how a TRBP-
PACT complex might influence PKR 
activity. TRBP and/or PACT are also 
critically involved in HIV biology (13, 21, 
43, 45), transcriptional gene silencing (46), 
translational control (33, 44) and ear 
development (47). Plausibly, the interaction 
between TRBP and PACT may provide a 
platform or a common regulatory point for 
multiple pathways including RNA silencing 
and PKR signaling.   
While TRBP and PACT have been 
shown to be necessary for RNA silencing in 
mammalian cells (10-12), their exact roles in 
Dicer and RISC function are obscure. While 
one report has suggested that depletion of 
TRBP by siRNAs reduces the level of 
mature miRNA (10), in another study this 
reduction has not been observed and TRBP 
depletion has been demonstrated to affect 
pre-miRNA processing in vitro (11). We 
showed that recombinant Dicer associated 
with TRBP and/or PACT is more active than 
Dicer alone in cleaving dsRNA into siRNAs 
(Fig. 5). Consistent with these results, we 
observed that knockdown of TRBP and 
PACT suppressed siRNA production and 
shRNA-mediated gene silencing in cultured 
cells, but had no influence on siRNA-
induced silencing (Fig. 6). While we do not 
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exclude the possibilities that TRBP and 
PACT are required for other aspects of Dicer 
function and RISC assembly as previously 
shown by others (10-12), our data suggest 
that they function primarily in facilitating 
the production of siRNAs. Although the 
knockdown of Dicer could effectively rescue 
the siRNA-induced silencing effect in our 
experiment (Fig. 6), at this point we still do 
not understand fully whether the use of a 
highly effective siRNA and a different cell 
line could possibly account for the 
discrepancies between our results and those 
from other groups (10-12, 48, 49). However, 
our finding that purified TRBP and PACT 
proteins facilitate the cleavage of dsRNA by 
Dicer (Fig. 5) is generally consistent with 
the previous observations that depletion of 
TRBP inhibits pre-miRNA processing in 
vitro (11) and that Loquacious in Drosophila 
stimulates pre-miRNA processing by Dicer-
1 (7, 35). This function of TRBP and PACT 
is also reminiscent of the role of Dicer-
associated RDE-4 in C. elegans (36, 50). We 
are currently in the process of comparing the 
pre-miRNA-cleaving activities of Dicer and 
TRBP-PACT-Dicer. This and other 
experiments will help clarify the roles of 
TRBP and PACT in siRNA and miRNA 
production.       
Our in vitro Dicer cleavage experiments 
did not show cooperation between TRBP 
and PACT (Fig. 5), whereas the knockdown 
experiments indicated a synergistic effect 
(Fig. 6). One possibility is that other proteins 
or factors in the cell could be required for 
the cooperation of TRBP with PACT. 
Alternatively, the protein concentrations 
used in the reconstituted cleavage reaction 
might not be optimal for the cooperation to 
occur. Further experiments are required to 
clarify the discrepancy.  
    
FOOTNOTES 
 
The abbreviations used are: dsRNA, double-stranded RNA; dsRBD, dsRNA binding domain; 
dsRBP, dsRNA binding protein; miRNA, microRNA; RNAi, RNA interference; RISC, RNA-
induced silencing complex; shRNA, short hairpin RNA; siRNA, small interfering RNA; 
FRET, fluorescence resonance energy transfer; MBP, maltose binding protein; GST, 
glutathione S transferase;   
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FIGURE LEGENDS 
 
FIGURE 1. TRBP interacts directly with PACT. A, binding between GST-TRBP and His-
PACT. Indicated GST fusion proteins were mixed with His-PACT (lane 1-6) at 4oC for 4 hrs. 
Proteins bound to glutathione-Sepharose beads were washed with 0.2 M (lanes 1-3) or 0.5 M 
NaCl (lanes 4-6) and then eluted with SDS loading buffer.  Eluted proteins and 5% of the 
input proteins were analyzed by Western blotting with anti-His (α-His) and anti-GST (α-
GST) antibodies. GST-T: GST-TRBP. GST-P: GST-PACT. His-P: His-PACT. B, binding 
between GST-PACT and MBP-TRBP. Indicated GST fusion proteins were mixed with MBP-
TRBP (MBP-T; lanes 2, 4 and 6) or His-PACT (His-P; lanes 1, 3 and 5). Proteins bound to 
glutathione-Sepharose beads were washed with 0.5 M NaCl, eluted and analyzed with anti-
His (α-His) and anti-MBP (α-MBP) antibodies as in A. C, domain mapping. The three 
dsRBDs in TRBP and PACT were depicted. GST pull down was carried out with the 
indicated GST fusion and His-tagged proteins as in A. Western blotting was performed with 
anti-His antibodies. TRBP-A/B/C contain amino acids 1-98, 104-227 and 234-359 of TRBP, 
while PACT-A/B/C correspond to amino acids 1-120, 133-234 and 247-314 of PACT. D, 
reciprocal co-immunoprecipitation. HEK293T cells were transfected with plasmids 
expressing the indicated combinations of Myc-TRBP (Myc-T) and V5-PACT (V5-P) 
proteins. Co-immunoprecipitation was carried out in the presence of RNase A (25 µg/ml) 
with anti-Myc (Myc-IP; lanes 3 and 4) and anti-V5 antibodies (V5-IP; lanes 7 and 8). Input 
proteins and immunoprecipitates were analyzed by Western blotting with anti-Myc (α-Myc) 
and anti-V5 (α-V5) antibodies. Arrows point to the heavy chain of immunoglobulins (Ig). 
Similar results were obtained when Myc-T and V5-P proteins were expressed in separate 
cells and the lysates of different cells were mixed immediately before immunoprecipitation 
was carried out (data not shown).                                                                                                                          
 
FIGURE 2. FRET analysis of the interaction between TRBP and PACT in HeLa cells. 
Cells were transfected to express CFP-TRBP (panels 1-3), YFP-PACT (panels 4-6) and CFP-
TRBP + YFP-PACT (lanes 7-9). In CFP channel, cells were excited at 820 nm and emission 
was recorded at 435-485 nm (panels 1, 4 and 7). In YFP channel, cells were excited at 488 
nm and emission was recorded at 535-590 nm (panels 2, 5 and 8). When cells were excited at 
820 nm, corrected FRET signal was simultaneously recorded at 535-590 nm (panels 3, 6 and 
9). Results were representative of 100 transfected cells. Bar, 20 µM.  
 
FIGURE 3. Formation of a triple complex of TRBP, PACT and Dicer in vitro and in 
cultured cells. A, triple complex formation in vitro. The indicated combinations of proteins 
were loaded onto glutathione-Sepharose beads. In lanes 3 and 6, MBP-TRBP/His-PACT and 
Dicer were loaded sequentially and unbound proteins were removed by extensive washing 
with 0.5 M NaCl. Bound proteins were eluted and analyzed by Western blotting with anti-
Dicer, anti-MBP, anti-His and anti-GST antibodies. MBP-T: MBP-TRBP. His-P: His-PACT. 
GST-P: GST-PACT. GST-T: GST-TRBP. B, triple complex formation in cultured cells. 
HEK293Tcells were co-transfected with plasmids expressing the indicated combinations of 
T7-Dicer, Myc-TRBP (Myc-T) and V5-PACT (V5-P) proteins. Co-immunoprecipitation was 
carried out in the presence of RNase A (25 µg/ml) with anti-Myc (Myc-IP; lanes 3-4) and 
anti-V5 (V5-IP; lanes 7-8) antibodies. Input proteins and immunoprecipitates were analyzed 
by Western blotting with anti-T7 (upper panel), ant-Myc (middle panel) and anti-V5 (lower 
panel). Target proteins are highlighted with “∗”, “#” and “►”. Arrows point to the heavy 
chain of immunoglobulins. Similar results were obtained when Myc-T, V5-P and T7-Dicer 
proteins were expressed in separate cells and the lysates of different cells were mixed 
immediately before immunoprecipitation was carried out (data not shown). C, summary of 
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protein-protein interactions. All interactions were based on in vitro GST pull down assay 
except that the binding to Dicer in cells was defined by co-immunoprecipitation of proteins 
from extracts of transfected HeLa cells.                                   
  
FIGURE 4. Formation of a triple complex of TRBP, PACT and Dicer in mouse testicular 
tissue. A, fractionation analysis. Mouse testes were fractionated by Superdex 200 gel 
filtration and column fractions were analyzed by Western blotting with anti-TRBP (α-T), 
anti-PACT (α-P) and anti-Dicer (α-D) antibodies. Similar results were obtained when protein 
complex was first pulled down with anti-PACT or anti-TRBP (data not shown). B, co-
immunoprecipitation. Extracts of mouse testes were co-immunoprecipitated with anti-TRBP. 
Input proteins, anti-TRBP serum and immunoprecipitates were analyzed by Western blotting 
with the indicated antibodies. 
 
FIGURE 5. TRBP and PACT facilitate siRNA production by Dicer. A, in vitro Dicer 
cleavage assay. In vitro transcribed dsRNA of 566 bp in length (dsRL566; 5 µg) was 
incubated with 2 units of recombinant Dicer for 16 hours at 37oC (lane 2). Increasing 
amounts of GST-TRBP (lanes 4-6; 0.2, 0.5 and 1 µM), His-PACT (lanes 7-9; 0.2, 0.5 and 
1µM) and GST-TRBP plus His-PACT (lanes 10-12; 0.2, 0.5 and 1 µM) were added into the 
reactions. Cleaved RNA was analyzed by 15% urea polyacrylamide gel electrophoresis. An 
inverted gel image was shown and the arrow points to siRL product. Lane 1 contains 40 
pmols of synthetic siRL as a positive control. B, quantitative analysis of results shown in A. 
Intensity of bands was quantified by Axo software, version 2.1. The readout from Dicer alone 
(lane 3) was taken as 100%. Values shown represent means ± SD from three independent 
experiments.  
 
FIGURE 6. TRBP and PACT are required for shRNA-mediated gene silencing. A and B, 
knockdown of TRBP and PACT expression by shRNA. HEK293T cells were transfected 
with Myc-TRBP or V5-PACT expression plasmid plus an empty vector (mock; lane 1) or 
plus expression vector for shTRBP, shPACT or shGFP (lanes 2-4). Expression of TRBP and 
PACT was determined by Western blotting with anti-Myc or anti-V5. C, Northern blot 
analysis of siRL production. HEK293T cells were transfected with shRL (lanes 2-5; 8 µg) 
and shTRBP (lane 3; 8 µg), shPACT (lane 4; 8 µg), or shTRBP plus shPACT (lane 5, 4 µg 
each). 32P-end-labeled RNA oligos were used for hybridization with shRL precursor (~ 70 bp) 
and siRL cleavage product (~ 21 bp). RNA (20 µg per lane) was analyzed by 12% denaturing 
polyacrylamide gel electrophoresis. Lane 1 contains 1 pmol of synthetic siRL as a positive 
control. D, influence of TRBP and PACT knockdown on shRNA activity. HEK293T cells 
were transfected with pRLCMV (20 ng),  pGL3-control (20 ng), shRL (lanes 2-5, 7-10 and 
12-15; 15 ng) and escalating amounts of shTRBP (lanes 3-5; 20, 50 and 100 ng), shPACT 
(lanes 8-10; 20, 50 and 100 ng) or shTRBP plus shPACT (lanes 13-15; 20, 50 and 100 ng). 
Lane 16 contains shRL (15 ng) and shGFP (100 ng) as a control for non-specific shRNA. 
Lane 17 is the same as lane 5 except that cells were co-transfected with pcDNA-TRBP (200 
ng). Lane 18 is the same as lane 10 except that cells were co-transfected with pcDNA-PACT 
(200 ng). Renilla luciferase activity was normalized to firefly luciferase activity. Readouts 
from no shRNA controls (lanes 1, 6 and 11) were set to 100%. Results represent three 
independent experiments and error bars indicate SD. The difference between lane 13 and lane 
3 (*) or between lane 13 and lane 8 (#) was statistically significant (P < 0.005 by t-test). E, 
influence of TRBP and PACT knockdown on siRNA activity. The experimental setting was 
the same as in A, except that 20 nM of siRL was added instead of shRL. Lane 16 contains 
siRL (20 nM) and siDicer (20 nM) as a positive control. 
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FIGURE 7. A working model for the interaction of TRBP, PACT and Dicer. TRBP (T) 
and PACT (P) directly interact with each other and associate with Dicer. This triple complex 
mediated the production of siRNA from either dsRNA or shRNA.  
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